Trending ASX Stocks in 2026

The following ASX stocks have stood out in 2026 because of impressive operational milestones and favourable industry tailwinds that support its long-term growth prospects.

Megaport Limited (ASX: MP1)

Megaport Limited (ASX: MP1) is one of the top ASX trending stocks in 2026 with a current market capitalisation of about $4.41 billion and in the first half of FY2026 reported strong results because high demand for its Network as a Service platform and recent acquisitions drove growth across the business.
The company in H1 FY2026 reported revenue of $134.9 million which was up 26% from the prior corresponding period while gross profit rose 31% to $97.6 million.

Recent developments included the acquisitions of Latitude.sh and Extreme IX expansion into India through 40 data centres deployment of AI ready GPU infrastructure and investment in product innovation which contributed more than 30% of ARR growth in H1 FY2026.

Management raised the lower end of its FY2026 revenue guidance for the core Megaport business and expects the combined group to report revenue of $302 million to $317 million with an EBITDA margin of 21% to 24%.

The company also believes artificial intelligence has become a major tailwind because rising demand for data movement and GPU computing increases the value of its physical digital infrastructure and positions Megaport for lucrative years ahead.

Macquarie Group Limited (ASX: MQG)

Macquarie Group Limited (ASX: MQG) is one of the top ASX trending stocks with a current market capitalisation of approximately $97.7 billion and achieved a record FY2026 performance while its share price rose 25.3% year-to-date.

The company in FY2026 reported net operating income of $19.48 billion which increased 13% from the prior corresponding period. Profit attributable to shareholders rose 30% to $4.85 billion while operating profit before tax increased 33% to $6.73 billion. Annualised return on equity improved to 14.0% and the full year dividend increased to $7.00 per share from $6.50 in FY2025.

Recent developments included the sale of the OnStream meters platform along with the expansion of its private credit portfolio and growth in Banking and Financial Services and home loans. 

The company also benefits from high-quality operating metrics with $722.1 billion in assets under management and a well-diversified earnings base which reduces reliance on any single business segment.

Pro Medicus Limited (ASX: PME)

Pro Medicus Limited (ASX: PME) is one of the Top ASX trending stocks with a current market capitalisation of approximately $18.5 billion and has built a strong position as a global leader in enterprise medical imaging software through its scalable and lucrative business model.

The company in the first half of FY2026 reported revenue of $124.8 million which was up 28.4% from the prior corresponding period while underlying EBIT increased 29.7% to $90.7 million with an exceptional EBIT margin of 72.6%. It ended the period with $221.8 million in cash and investments and remained completely debt free.

Pro Medicus on 4 June 2026 secured a five-year $16 million contract renewal with The Ohio State University Wexner Medical center which increased both minimum transaction volumes and transaction fees while total contract renewals during the financial year reached $141 million and highlighted its industry-leading client retention.

The company also announced a strategic partnership with Echo IQ on 25 June 2026 which included an initial $10 million investment with the option to invest a further $10 million following FDA clearance along with a reseller agreement that will allow Pro Medicus to market AI-powered cardiovascular software across its extensive US customer network.

(Source: Company Announcements)